Literature DB >> 21909879

The role of annexin A2 in tumorigenesis and cancer progression.

Noor A Lokman1, Miranda P Ween, Martin K Oehler, Carmela Ricciardelli.   

Abstract

Annexin A2 is a calcium-dependent, phospholipid-binding protein found on various cell types. It is up-regulated in various tumor types and plays multiple roles in regulating cellular functions, including angiogenesis, proliferation, apoptosis, cell migration, invasion and adhesion. Annexin A2 binds with plasminogen and tissue plasminogen activator on the cell surface, which leads to the conversion of plasminogen to plasmin. Plasmin is a serine protease which plays a key role in the activation of metalloproteinases and degradation of extracellular matrix components essential for metastatic progression. We have recently found that both annexin A2 and plasmin are increased in conditioned media of co cultured ovarian cancer and peritoneal cells. Our studies suggest that annexin A2 is part of a tumor-host signal pathway between ovarian cancer and peritoneal cells which promotes ovarian cancer metastasis. Accumulating evidence suggest that interactions between annexin A2 and its binding proteins play an important role in the tumor microenvironment and act together to enhance cancer metastasis. This article reviews the current knowledge on the biological role of annexin A2 and its binding proteins in solid malignancies including ovarian cancer.

Entities:  

Year:  2011        PMID: 21909879      PMCID: PMC3170418          DOI: 10.1007/s12307-011-0064-9

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  110 in total

Review 1.  Tenascin-C induced signaling in cancer.

Authors:  Gertraud Orend; Ruth Chiquet-Ehrismann
Journal:  Cancer Lett       Date:  2006-04-24       Impact factor: 8.679

2.  Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.

Authors:  Jian Zhang; Bianqin Guo; Yan Zhang; Ju Cao; Tingmei Chen
Journal:  Saudi Med J       Date:  2010-04       Impact factor: 1.484

3.  Knockdown of annexin 2 decreases migration of human glioma cells in vitro.

Authors:  L Tatenhorst; U Rescher; V Gerke; W Paulus
Journal:  Neuropathol Appl Neurobiol       Date:  2006-06       Impact factor: 8.090

4.  Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.

Authors:  K Emoto; Y Yamada; H Sawada; H Fujimoto; M Ueno; T Takayama; K Kamada; A Naito; S Hirao; Y Nakajima
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

Review 5.  Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

Authors:  Pomila Singh
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

6.  Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2.

Authors:  K A Hajjar; C A Guevara; E Lev; K Dowling; J Chacko
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

7.  Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

Authors:  Kamala Kesavan; Judson Ratliff; Eric W Johnson; William Dahlberg; John M Asara; Preeti Misra; John V Frangioni; Douglas B Jacoby
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

8.  Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion.

Authors:  Ursula Rescher; Carsten Ludwig; Vera Konietzko; Alexei Kharitonenkov; Volker Gerke
Journal:  J Cell Sci       Date:  2008-07-01       Impact factor: 5.285

9.  Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.

Authors:  Fei Zhang; Lin Zhang; Bin Zhang; Xiyin Wei; Yi Yang; Robert Z Qi; Guoguang Ying; Ning Zhang; Ruifang Niu
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

10.  Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells.

Authors:  T J Yeatman; T V Updyke; M A Kaetzel; J R Dedman; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

View more
  94 in total

1.  Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2.

Authors:  Kelly Foley; Stephen Muth; Elizabeth Jaffee; Lei Zheng
Journal:  Cell Adh Migr       Date:  2017-02-06       Impact factor: 3.405

2.  Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion.

Authors:  Hannah Johnson; Rebecca S Lescarbeau; Jesus A Gutierrez; Forest M White
Journal:  J Proteome Res       Date:  2013-03-11       Impact factor: 4.466

3.  S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells.

Authors:  Jyoti K Jaiswal; Jesper Nylandsted
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.

Authors:  Nevine El-Abd; Amal Fawzy; Tamer Elbaz; Sherif Hamdy
Journal:  Tumour Biol       Date:  2015-07-20

5.  HFIP extraction followed by 2D CTAB/SDS-PAGE separation: a new methodology for protein identification from tissue sections after MALDI mass spectrometry profiling for personalized medicine research.

Authors:  Rémi Longuespée; Christophe Tastet; Annie Desmons; Olivier Kerdraon; Robert Day; Isabelle Fournier; Michel Salzet
Journal:  OMICS       Date:  2014-05-19

6.  Signals involved in the effects of bisphenol A (BPA) on proliferation and motility of Leydig cells: a comparative proteomic analysis.

Authors:  Zhuo-Jia Chen; Kun-Shui Zhang; Li-Chen Ge; Hao Liu; Li-Kun Chen; Jun Du; Hong-Sheng Wang
Journal:  Toxicol Res (Camb)       Date:  2016-09-13       Impact factor: 3.524

7.  ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.

Authors:  Nicholas B Griner; Denise Young; Pankaj Chaudhary; Ahmed A Mohamed; Wei Huang; Yongmei Chen; Taduru Sreenath; Albert Dobi; Gyorgy Petrovics; Jamboor K Vishwanatha; Isabell A Sesterhenn; Shiv Srivastava; Shyh-Han Tan
Journal:  Mol Cancer Res       Date:  2014-10-24       Impact factor: 5.852

8.  RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.

Authors:  Fengmei Pi; Hui Zhang; Hui Li; Varatharasa Thiviyanathan; David G Gorenstein; Anil K Sood; Peixuan Guo
Journal:  Nanomedicine       Date:  2016-11-25       Impact factor: 5.307

9.  Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]pyrimidines for Targeting Hepatocellular Carcinoma.

Authors:  Pierpaolo Calandro; Giulia Iovenitti; Claudio Zamperini; Francesca Candita; Elena Dreassi; Mario Chiariello; Adriano Angelucci; Silvia Schenone; Maurizio Botta; Arianna Mancini
Journal:  ACS Med Chem Lett       Date:  2018-05-07       Impact factor: 4.345

10.  Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.

Authors:  Uzoma K Iheagwara; Pamela L Beatty; Phu T Van; Ted M Ross; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2013-12-05       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.